Yale Institute for Global Health

52 results

Rate Search Results

News
ASBMB names 2025 award winners
Herbert Tabor Research Award from the ASBMB is awarded to Joseph Schlessinger.
Source: ASBMB Today
21 Aug 2024
News
Genetic Analysis of Rare, Often Deadly Cervical Cancer Uncovers Potential Treatments
Yale Cancer Center researchers at Yale School of Medicine analyze the genetic landscape of 66 tumors, the largest series of cervical neuroendocrine tumors ever reported in scientific literature.
15 Apr 2024
News
Yale Scientists Receive $10.5M for ‘Team Science’ Exploration of Membrane Proteins in Their Natural Environment
An interdisciplinary team of Yale scientists is coming together to address crucial questions about how the cell membrane environment affects membrane proteins, with support from the National Institute of General Medical Sciences (NIGMS).
Source: Yale West Campus
28 Jun 2023
News
Yale Researchers Awarded $12M NIH Grant to Study Impact of FGF21 Protein on Aging
Researchers from Yale University, and the University of Texas Southwestern Medical Center have been awarded a $12.4 million, five-year grant from the National Institute on Aging of the NIH to deploy their unique research models and expertise in a coordinated fashion to develop a novel course of gerontological research.
24 Oct 2022
News
Yale Researchers have Uncovered a Regulator of Body Weight that could Lead to New Treatments for Metabolic Disorders
Yale scientists have discovered that a protein known as augmentor-alpha regulates body weight in mice, an insight that could lead to new treatments for metabolic disorders.
11 Apr 2022
News
Scientists Uncover Key Regulator of Body Weight
Yale scientists have discovered that a protein known as augmentor-alpha regulates body weight in mice, an insight that could lead to new treatments for metabolic disorders.
Source: YaleNews
11 Apr 2022
News
Yale scientists uncover key regulator of body weight
Yale scientists have discovered that a protein known as augmentor-alpha can regulate body weight, an insight that may lead to new treatments for metabolic disorders.
Source: Yale News
11 Apr 2022
News
The Growth of the Cancer Biology Institute
Six years after laying out an ambitious blueprint for the Yale Cancer Biology Institute, much of it has been realized by recruiting scientists with unlimited potential and offering them their first labs. Led by Mark Lemmon, PhD, FRS, the institute has been built around young scientists he calls “superstars.”
30 Mar 2022
News
Yale Cancer Center Researchers Show Receptor Structure Reveals New Targets for Cancer Treatment
Two new studies by Yale Cancer Center reveal the structure of the molecule known as anaplastic lymphoma kinase, which is a driver of several cancers, including pediatric neuroblastoma, B-cell lymphomas, and myofibroblast tumors.
Source: OncLive
9 Dec 2021
News
Yale Cancer Center Researchers Show Receptor Structure Reveals New Targets for Cancer Treatments
A molecule known as anaplastic lymphoma kinase is a driver of several cancers, including pediatric neuroblastoma, B-cell lymphomas, and myofibroblast tumors, according to a new study by Yale Cancer Center researchers.
23 Nov 2021
News
Department of Pharmacology Mini-symposium on Feb. 11
The Department of Pharmacology is hosting a mini-symposium titled, "The Biology of Endocrine FGFs: From Basic Mechanisms to Therapeutic Opportunities" on Monday, February 11th, 2019 from 9:30am to 12:30pm (TAC N107). This mini-symposium will feature three separate lectures from three distinguished speakers.
13 Jan 2019
News
Yale Cancer Center researchers find genetic explanations behind the rapid spread of ovarian cancer
In a breakthrough study, Yale Cancer Center (YCC) researchers have defined the genetic characteristics of primary, metastatic and recurrent ovarian tumors and evaluated new targeted therapies to treat the disease. The findings are reported today in the Proceedings of the National Academy of Science (PNAS) online early edition.
23 Dec 2018
News
Researchers find genes behind aggressive ovarian and endometrial cancers
In a major breakthrough for ovarian and uterine cancers, Yale researchers have defined the genetic landscape of rare, highly aggressive tumors called carcinosarcomas (CSs), pointing the way to possible new treatments. The findings are published in the Oct. 10 online early edition of Proceedings of the National Academy of Sciences.
10 Oct 2016
News
Researchers find genes behind aggressive ovarian and endometrial cancers
In a major breakthrough for ovarian and uterine cancers, Yale researchers have defined the genetic landscape of rare, highly aggressive tumors called carcinosarcomas (CSs), pointing the way to possible new treatments.
10 Oct 2016
News
Yale researcher Joseph Schlessinger Named Fellow of the AACR Academy
Yale cancer researcher Joseph “Yossi” Schlessinger, PhD, has been named to the 2016 Class of Fellows of the American Association of Cancer Research (AACR) Academy.
5 Apr 2016
News
Yale study examines evolution of cancer
A novel Yale study answers age-old questions about how cancers spread by applying tools from evolutionary biology. The new insights will help scientists better understand the genetic origins of tumor metastases, and lead to more effective targets for treatment, said the researchers. The study, led by associate professor of public health (biostatistics) Jeffrey Townsend, was published on Feb. 8 by the Proceedings of the National Academy of Sciences.
7 Feb 2016
News
Chair of pharmacology honored by Spanish foundation
Hormones such as insulin and growth factors mediate their many physiological responses by activating a family of enzymes known as tyrosine kinases. Because of their roles as “drivers” of many cancers, tyrosine kinases have become a favorite target within the field of personalized cancer therapy:..
15 Jun 2015
News
Kolltan Pharmaceuticals’ Dr. Joseph Schlessinger Named to Medicine Maker Power List 2015
Kolltan Pharmaceuticals, Inc. today announced that Joseph Schlessinger, Ph.D., Chairman of the Department of Pharmacology and the William H. Prusoff Professor at Yale University School of Medicine, as well as founding director of Yale’s Cancer Biology Institute and co-founder of Kolltan, has been named one of the top 100 most influential people in drug development and manufacture by the publication The Medicine Maker.
Source: BusinessWire
15 May 2015
News
FN 04: Joseph Schlessinger
Joseph Schlessinger, Ph. D.
8 May 2015
News
Yale scientist wins international award for discoveries leading to new class of cancer drugs
A Spanish foundation has awarded a major scientific prize to Yale researcher Joseph Schlessinger, PhD, and two colleagues in recognition of their work leading to the first personalized treatments for cancer. The 2015 Frontiers of Knowledge Award in Biomedicine from the Madrid-based BBVA Foundation includes a €400,000 cash prize.
26 Jan 2015